Jena, December 14, 2009 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) has increased its stake in CyBio AG, also based in Jena/Thuringia. CyBio specializes in the high throughput pharmaceuticals niche market.

The increase took place as part of a capital increase by CyBio AG granting shareholders subscription rights. This capital increase involved the issue of 1,800,000 new no-par value bearer shares at a subscription price of EUR 1.0 per share. The majority shareholder Analytik Jena AG exercised 1,178,126 subscription rights. 64,593 subscription rights were exercised by other shareholders. The 557,281 shares not subscribed to by the old shareholders were transferred to Analytik Jena AG in the course of a private placement after the end of the subscription period.

Analytik Jena AG now holds a total of 5,269,785 shares in CyBio AG and has a 73.19 % stake in the company’s share capital.